Maze Therapeutics, Inc.(MAZE:US)
Market Cap$1.369B
Key Metrics
Price$27.53
Revenue (TTM)$20M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$122.54M
EBITDA (TTM)-$128.68M
Op. Margin (TTM)-670.25%
Dividend Yield-
Holders Yield-
Cash on hand$198.77M
Total Assets$419.71M
Net Assets$341.7M
Total Debt$61.22M
Key Metrics
Price$27.53
Revenue (TTM)$20M
Holders Revenue (TTM)-
Gross Profit (TTM)-
Earnings (TTM)-$122.54M
EBITDA (TTM)-$128.68M
Op. Margin (TTM)-670.25%
Dividend Yield-
Holders Yield-
Cash on hand$198.77M
Total Assets$419.71M
Net Assets$341.7M
Total Debt$61.22M
Financials
| Name | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $20M | $0 | $0 | $0 | $0 | $0 | $2.5M | $165M | $0 | $0 |
Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - |
| $46.55M | $38.06M | $32.97M | $36.47M | $35.4M | $29.73M | $26.73M | $25.45M | $23.05M | $25.23M | |
| Research and Development | $34.15M | $27.57M | $25.19M | $28.11M | $27.58M | $22.22M | $19.86M | $19.55M | $16.05M | $19.46M |
| Selling, General, and Administrative | $12.41M | $10.49M | $7.78M | $8.37M | $7.82M | $7.51M | $6.87M | $5.9M | $7.01M | $5.77M |
| Other Operating Expenses | - | - | - | - | - | - | - | - | - | - |
Operating Income | -$26.55M | -$38.06M | -$32.97M | -$36.47M | -$35.4M | -$29.73M | -$24.23M | $139.56M | -$23.05M | -$25.23M |
| $2.35M | $3.49M | $2.88M | $2.8M | $2.62M | -$128K | -$802K | $1.23M | $304K | $481K | |
| Non-Operating Interest Income | $3.21M | $3.49M | $2.88M | $2.8M | $2.62M | $1.52M | $1.85M | $1.01M | $304K | $481K |
| Non-Operating Interest Expense | $866K | - | - | - | - | - | - | - | - | - |
| Other Income/Expense | - | - | - | - | - | -$1.64M | -$2.65M | $216K | - | - |
Income Before Tax | -$24.21M | -$34.57M | -$30.09M | -$33.68M | -$32.79M | -$29.85M | -$25.03M | $140.78M | -$26.58M | -$24.75M |
Income Tax | - | $0 | $0 | $0 | - | -$275K | -$279K | - | - | $0 |
Net Income | -$24.21M | -$34.57M | -$30.09M | -$33.68M | -$32.79M | -$29.58M | -$24.75M | $139.06M | -$26.58M | -$24.75M |
Minority Interests | - | - | - | - | - | - | - | - | - | - |
Preferred Stock Dividends | - | $0 | $0 | $0 | - | -$39.65M | -$22.33M | - | - | $0 |
Net Income to Common | -$24.21M | -$34.57M | -$30.09M | -$33.68M | -$32.79M | $10.07M | -$2.43M | $139.06M | -$26.58M | -$24.75M |
Shares Outstanding (Basic) | 53.9M | 53.4M | 45.78M | 43.8M | 28.63M | 43.78M | - | - | - | - |
Shares Outstanding (Diluted) | 53.9M | 53.4M | 45.78M | 43.8M | 28.63M | 43.78M | - | - | - | - |
EPS (Basic) | -$0.45 | -$0.65 | -$0.66 | -$0.77 | -$1.15 | -$1.02 | - | - | - | - |
EPS (Diluted) | -$0.45 | -$0.65 | -$0.66 | -$0.77 | -$1.15 | -$1.02 | - | - | - | - |
EBIT | -$23.34M | -$38.06M | -$32.97M | -$36.47M | -$35.4M | -$29.73M | -$24.23M | $139.56M | -$23.05M | -$25.23M |
EBITDA | -$22.9M | -$37.56M | -$32.39M | -$35.83M | -$34.72M | -$29.02M | -$23.44M | $140.41M | -$22.08M | -$24.22M |